BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 38529474)

  • 1. A programmable CRISPR/dCas9-based epigenetic editing system enabling loci-targeted histone citrullination and precise transcription regulation.
    Zhang X; Bhattacharya A; Pu C; Dai Y; Liu J; Rao L; Tian C
    J Genet Genomics; 2024 Jun; ():. PubMed ID: 38849111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical biology of protein citrullination by the protein A arginine deiminases.
    Mondal S; Thompson PR
    Curr Opin Chem Biol; 2021 Aug; 63():19-27. PubMed ID: 33676233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer.
    Albano C; Biolatti M; Mazibrada J; Pasquero S; Gugliesi F; Lo Cigno I; Calati F; Bajetto G; Riva G; Griffante G; Landolfo S; Gariglio M; De Andrea M; Dell'Oste V
    Front Cell Infect Microbiol; 2024; 14():1359367. PubMed ID: 38529474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
    Mondal S; Thompson PR
    Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression.
    Miller J; Dakic A; Spurgeon M; Saenz F; Kallakury B; Zhao B; Zhang J; Zhu J; Ma Q; Xu Y; Lambert P; Schlegel R; Riegel AT; Liu X
    J Med Virol; 2022 Aug; 94(8):3962-3977. PubMed ID: 35437795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
    Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
    Front Immunol; 2021; 12():716250. PubMed ID: 34737738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
    Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
    Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
    Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker.
    Shafique M; Shoaib I; Aslam B; Khalid R; Tanvir I; Rasool MH; Shah TA; Almaary KS; Bourhia M; Qamar MU
    Arch Microbiol; 2023 Dec; 206(1):17. PubMed ID: 38085340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors.
    Pasquero S; Gugliesi F; Biolatti M; Dell'Oste V; Albano C; Bajetto G; Griffante G; Trifirò L; Brugo B; Raviola S; Lacarbonara D; Yang Q; Sudeshna S; Barasa L; Haniff H; Thompson PR; Landolfo S; De Andrea M
    PLoS Pathog; 2023 Dec; 19(12):e1011849. PubMed ID: 38055760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT1 is an actionable target to restore p53 function in HPV-associated cancer therapy.
    Lo Cigno I; Calati F; Girone C; Borgogna C; Venuti A; Boldorini R; Gariglio M
    Br J Cancer; 2023 Nov; 129(11):1863-1874. PubMed ID: 37838812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity.
    Girone C; Calati F; Lo Cigno I; Salvi V; Tassinari V; Schioppa T; Borgogna C; Lospinoso Severini L; Hiscott J; Cerboni C; Soriani A; Bosisio D; Gariglio M
    Cancer Immunol Immunother; 2023 Sep; 72(9):3097-3110. PubMed ID: 37356050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomaviruses sensitize cells to DNA damage induced apoptosis by targeting the innate immune sensor cGAS.
    Gusho E; Laimins LA
    PLoS Pathog; 2022 Jul; 18(7):e1010725. PubMed ID: 35877778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlighting the versatility of the citrullination process.
    Sarnik J; Makowska JS
    Immunobiology; 2022 Jul; 227(4):152233. PubMed ID: 35667151
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.